Oncology Institute Inc
NASDAQ:TOI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Oncology Institute Inc
Interest Expense
Oncology Institute Inc
Interest Expense Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Interest Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Oncology Institute Inc
NASDAQ:TOI
|
Interest Expense
$11.3m
|
CAGR 3-Years
40%
|
CAGR 5-Years
101%
|
CAGR 10-Years
N/A
|
|
|
Universal Health Services Inc
NYSE:UHS
|
Interest Expense
$157.3m
|
CAGR 3-Years
7%
|
CAGR 5-Years
8%
|
CAGR 10-Years
4%
|
|
|
Encompass Health Corp
NYSE:EHC
|
Interest Expense
$123.2m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-1%
|
|
|
Tenet Healthcare Corp
NYSE:THC
|
Interest Expense
$821m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-1%
|
|
|
HCA Healthcare Inc
NYSE:HCA
|
Interest Expense
$2.2B
|
CAGR 3-Years
9%
|
CAGR 5-Years
7%
|
CAGR 10-Years
3%
|
|
|
Ensign Group Inc
NASDAQ:ENSG
|
Interest Expense
$8m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
11%
|
|
Oncology Institute Inc
Glance View
The Oncology Institute, Inc. provides cancer care treatment services. The company is headquartered in Cerritos, California. The company went IPO on 2020-03-13. The firm manages community-based oncology practices that serve patients at approximately 55 clinic locations across eight markets and four states throughout the United States. The Company’s managed clinics provide a range of medical oncology services, including physician services, in-house infusion and dispensary, clinical trial services, programs like outpatient stem cell transplants and transfusions, along with 24/7 patient support. Through the Innovative Clinical Research Institute (ICRI), the Company also provides and manages clinical trial services and research for the benefit of cancer patients. Its services, such as managing clinical trials, palliative care programs and stem cell transplants, are accessed through academic and tertiary care settings. Its managed clinics primarily serve adult and senior cancer patients in markets that have Medicare Advantage (MA) plans.
See Also
What is Oncology Institute Inc's Interest Expense?
Interest Expense
11.3m
USD
Based on the financial report for Dec 31, 2025, Oncology Institute Inc's Interest Expense amounts to 11.3m USD.
What is Oncology Institute Inc's Interest Expense growth rate?
Interest Expense CAGR 5Y
101%
Over the last year, the Interest Expense growth was 50%. The average annual Interest Expense growth rates for Oncology Institute Inc have been 40% over the past three years , 101% over the past five years .
